Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation

Pulmonary Circulation

Volumn 6, Issue 1, 2016, Pages 63-69

  DiBlasi, Robert M ^a   Crotwell, Dave N ^a   Shen, Shuijie ^a   Zheng, Jiang ^a   Fink, James B ^b   Yung, Delphine ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b Clados Management   (United States)

Author keywords

High frequency ventilation; Infant hypoxic lung disease; Inhaled pulmonary vasodilation; Neonatal ventilation; Pediatric aerosol delivery

Indexed keywords

EID: 84977508288     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/685080     Document Type: Article

References (28)

1. Grant SM, Goa KL. Iloprost: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992; 43(6): 889-924.
2. Harris KW, O’Riordan TG, Smaldone GC. Aerosolized iloprost customized for the critically ill. Respir Care 2007; 52(11): 1507-1509.
3. Tissot C, Beghetti M. Review of inhaled iloprost for the control of pulmonary artery hypertension in children. Vasc Health Risk Manag 2009; 5: 325-331.
4. Kahveci H, Yilmaz O, Avsaer UZ, Ciftel M, Kilic O, Laloglu F, Ozturk K. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn. Pediatr Pulmonol 2014; 49(12): 1205-1213.
5. Yilmaz O, Kahveci H, Zeybek C, Ciftel M, Kilic O. Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension. Am J Perinatol 2014; 31(4): 321-326.
6. Ivy DD, Doran AK, Smith KJ, Mallory GB Jr., Beghetti M, Barst RJ, Brady D, et al. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51(2): 161-169.
7. Collaco JM, Romer LH, Stuart BD, Coulson JD, Everett AD, Lawson EE, Brenner JI, et al. Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol 2012; 47 (11): 1042-1053.
8. Brown AT, Gillespie JV, Miquel-Verges F, Holmes K, Ravekes W, Spevak P, Brady K, et al. Inhaled epoprostenol therapy for pulmonary hypertension: improves oxygenation index more consistently in neonates than in older children. Pulm Circ 2012; 2(1): 61-66.
9. Piastra M, De Luca D, De Carolis MP, Tempera A, Stival E, Caliandro F, Pietrini D, et al. Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series. Pediatr Pulmonol 2012; 47(8): 757-762.
10. Ehlen M, Wiebe B. Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young 2003; 13: 361-363.
11. Eifinger F, Sreeram N, Mehler K, Huenseler C, Kribs A, Roth B. Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study. Klin Padiatr 2008; 220(2): 66-69.
12. Chotigeat U, Jaratwashirakul S. Inhaled iloprost for severe persistent pulmonary hypertension of the newborn. J Med Assoc Thai 2007; 90: 167-170.
13. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141: 830-832.
14. Abman SH, Kinsella JP, Rosenzweig EB, Krishnan U, Kulik T, Mullen M, Wessel DL, et al.; Pediatric Pulmonary Hypertension Network (PPHNet). Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med 2013; 187(6): 572-575.
15. Loukanov T, Bucsenez D, Springer W, Sebening C, Rauch H, Roesch E, Karck M, et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clinical Res Cardiol 2011: 100(7): 595-602.
16. Yilmaz O, Kahveci H, Zeybek C, Ciftel M, Kilic O. Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension. Am J Perinatol 2014; 31(4): 321-326.
17. Kirbas A, Yalcin Y, Tanrikulu N, Gürer O, Isik O. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiol J 2012; 19(4): 387.
18. Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 2010; 55(7): 837-844.
19. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010; 55(7): 845-851.
20. Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care 2013; 58(7): 1124-1133.
21. Berlinski A, Willis JR. Effect of tidal volume and nebulizer type and position on albuterol delivery in a pediatric model of mechanical ventilation. Respir Care 2015; 60(10): 1424-1430.
22. Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaled in a pediatric high-frequency oscillatory ventilation mode. Crit Care Med 2000; 28(6): 2086-2089.
23. DiBlasi RM, Richardson CP, Hansen T. Pulmonary physiology of the newborn. In: Gleason A, Devasker S, eds. Avery’s diseases of the newborn. 9th ed. Philadelphia: Saunders, 2012: 44-1-44-13.
24. Dubus JC, Vecellio L, De Monte M, Fink JB, Grimbert D, Montharu J, Valat C, et al. Aerosol deposition in neonatal ventilation. Pediatr Res 2005; 58(1): 10-14.
25. Farney KD, Kuehne BT, Gibson LA, Nelin LD, Shepherd EG. In vitro evaluation of radio-labeled aerosol delivery via a variable-flow infant CPAP system. Respir Care 2014; 59(3): 340-344.
26. Alzahrani W, Harwood R, Fink J, Goodfellow L, Ari A. Comparison of albuterol delivery between high frequency oscillatory ventilation and conventional mechanical ventilation in a simulated adult lung model using different compliance levels (abstract). Respir Care 2010; 55(11): 1576.
27. Sood BG, Peterson J, Malian M, Galli R, Geisor-Walter M, McKinnon J, Sharp J, Maddipati KR. Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res 2007; 56(6): 531-541.
28. Sood BG, Latif Z, Shen Y, Galli RJ, Dunlap CW, Gemini MJ, Haacke EM. Aerosol delivery during high frequency jet ventilation: an MRI evaluation. Respir Care 2012; 57(11): 1901-1907.